Current role of ischemia-modified albumin in routine clinical practice

References

• Anwaruddin S, Januzzi JLJr, Baggish AL, Lewandrowski EL, Lewandrowski KB. (2005). Ischemia modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting. Am J ClinPathol 123:140–5.
   Google Scholar
• Aparci M, Kardesoglu E, Ozmen N, Ozcan O, Cebeci BS, Cingozbay BY, Dincturk M. (2007). Prognostic significance of ischemia-modified albumin in patients with acute coronary syndrome. Coron Artery Dis 18:367–73.
   Google Scholar
• Apple FS, Wu AH, Mair J, Ravkilde J, Panteghini M, Tate J, Pagani F, Christenson RH, Mockel M, Danne O, Jaffe AS; Committee on Standardization of Markers of Cardiac Damage of the IFCC. (2005). Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. ClinChem 51:810–24.
   Google Scholar
• Bar-Or D, Lau E, Winkler JV.(2000). Novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia -a preliminary report.J Emerg Med 19:311–15.
   PubMed Web of Science ®Google Scholar
• Beetham R, Monk C, Keating L, Benger JR, Kendall J.(2006). Effects of storage at – 20 degrees C on ischemia-modified albumin results. Ann ClinBiochem43:500–2.
   PubMed Web of Science ®Google Scholar
• Bhagavant NV, Lai EM, Rios PA, Yang J, Ortega-Lopez AM, Shinoda H, Honda SAA, Rios CN, Sugiyama CE, Ha CE. (2003). Evaluation on human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem 49:581–5.
   Google Scholar
• Borderie D, Allanore Y, Meune C, Devaux JY, Ekindjian OG, Kahan A. (2004). High ischemia-modified albumin concentration reflects oxidative stress but not myocardial involvement in systemic sclerosis. ClinChem 50:2190–3.
   Google Scholar
• Can M, Demirtas S, Polat O, Yildiz A. (2006). Evaluation of effects of ischaemia on the albumin cobalt binding (ACB) assay in patients exposed to trauma. Emerg Med J 23:537–9.
   PubMed Web of Science ®Google Scholar
• Christenson RH, Azzazy HME. (1998). Biochemical markers of the acute coronary syndromes. ClinChem 44:1855–64.
   Google Scholar
• Christenson RH, Duh SH, Sanhai WR, Wu AH, Holtman V, Painter P, Branham E, Apple FS, Murakami M, Morris DL. (2001). Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study. ClinChem 47:464–70.
   Google Scholar
• Collinson PO, Gaze DC. (2007). Biomarkers of cardiovascular damage.Med PrincPract 16:247–61.
   Google Scholar
• Collinson PO, Gaze DC, Bainbridge K, Morris F, Morris B, Price A, Goodacre S. (2006). Utility of admission cardiac troponin and ‘Ischemia Modified Albumin’ measurements for rapid evaluation and rule out of suspected acute myocardial infarction in the emergency department. Emerg Med J 23:256–61.
   PubMed Web of Science ®Google Scholar
• Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez MJ, Samimi-Fard S, Kaski JC. (2008a). Relation of ischemia-modified albumin levels and left ventricular systolic function in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. ClinChimActa 388:196–9.
   PubMed Web of Science ®Google Scholar
• Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez MJ, Samimi-Fard S, Reiter RJ, Kaski JC. (2008b). Association of ischemia-modified albumin and melatonin in patients with ST-segment elevation myocardial infarction. Atherosclerosis 199:73–8.
   PubMed Web of Science ®Google Scholar
• Dominguez-Rodriguez A, Abreu-Gonzalez P, Jimenez-Sosa A, Samimi-Fard S, Idaira HB. (2009a). Does ischemia-modified albumin add prognostic value to the Thrombolysis In Myocardial Infarction risk score in patients with ST-segment elevation myocardial infarction treated with primary angioplasty? Biomarkers 14:43–8.
   PubMed Web of Science ®Google Scholar
• Dominguez-Rodriguez A, Kaski JC, Abreu-Gonzalez P, Samimi-Fard S. (2009b). Role of ischemia modified albumin to ST-segment resolution after mechanical reperfusion in patients with ST-segment elevation myocardial infarction. Atherosclerosis 203:576–80.
   PubMed Web of Science ®Google Scholar
• Duseja R, Feldman JA. (2004). Missed acute cardiac ischemia in the ED: limitations of diagnostic testing. Am J Emerg Med 22:219–25.
   PubMed Web of Science ®Google Scholar
• Fagan GJ, Wayment H, Morris DL, Crosby PA. (2002). The albumin cobalt binding test: analytical performance of a new automated chemistry assay for the detection of ischemia modified albumin (IMA). J Clin Ligand Assay 25:178–87.
   Google Scholar
• Falkensammer J, Stojakovic T, Huber K, Hammerer-Lercher A, Gruber I, Scharnagl H, Fraedrich G, Santner W, Schocke M, Greiner A. (2007). Serum levels of ischemia-modified albumin in healthy volunteers after exercise-induced calf-muscle ischemia. ClinChem Lab Med 45:535–40.
   Google Scholar
• Garrido IP, Roy D, Calviño R, Vazquez-Rodriguez JM, Aldama G, Cosin-Sales J, Quiles J, Gaze DC, Kaski JC. (2004). Comparison of ischemia-modified albumin levels in patients undergoing percutaneous coronary intervention for unstable angina pectoris with versus without coronary collaterals.Am J Cardiol 93:88–90.
   PubMed Web of Science ®Google Scholar
• Gaze DC. (2009). Ischemia modified albumin: a novel biomarker for the detection of cardiac ischemia. Drug MetabPharmacokinet 24:333–41.
   PubMed Web of Science ®Google Scholar
• Gaze DC, Crompton L, Collinson P. (2006). Ischemia-modified albumin concentrations shuold be interpreted with caution in patients with low serum albumin concentrations. Med PrincPract 15:322–4.
   PubMed Web of Science ®Google Scholar
• Gidenne S, Ceppa F, Fontan E, Perrier F, Burnat P. (2004). Analytical performance of the albumin cobalt binding (ACR®) test on the cobas MIRA® plus analyzer. ClinChem Lab Med 42:455–61.
   Google Scholar
• Govender R, De Greef J, Delport R, Becker PJ, Vermaak WJ. (2008). Biological variation of ischemia-modified albumin in healthy subjects. Cardiovasc J Afr 19:141–4.
   PubMed Web of Science ®Google Scholar
• Hakligor A, Kosem A, Senes M, Yucel D. (2010). Effect of albumin concentration and serum matriz on ischemia-modified albumin. ClinBiochem 43:345–8.
   PubMed Web of Science ®Google Scholar
• Hjortshøj S, Kristensen SR, Ravkilde J. (2010). Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome. Am J EmergMed 28:170–6.
   PubMed Web of Science ®Google Scholar
• Iuliano L, Pratico D, Greco C, Mangieri E, Scibilia G, FitzGerald GA, Violi F. (2001). Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTC. J Am CollCardiol 37:76–80.
   Google Scholar
• Jalan R, Schnurr K, Moorkerjee RP, Chshire L, Hodges S, Muravsky V, Williamns R, Matthes G, Davies NA. (2009). Alteration in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increase mortality. Hepatology 50:555–64.
   PubMed Web of Science ®Google Scholar
• Keating L, Benger JR, Beetham R, Bateman S, Veysey S, Kendall J, Pullinger R. (2006). The PRIMA study: presentation ischaemia-modified albumin in the emergency department. Emerg Med J 23:764–8.
   PubMedGoogle Scholar
• Lee YW, Kim HJ, Shin HB, Choi TY, Lee YK. (2007). Application of albumin-adjusted ischemia modified albumin index as an early screening marker for acute coronary syndrome.ClinChimActa 384:24–7.
   PubMed Web of Science ®Google Scholar
• Libby P. (2001). Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104:365–72.
   PubMed Web of Science ®Google Scholar
• Lippi G, Montagnana M, Guidi GC. (2006a). Albumin cobalt binding and ischemia modified albumin generation: an endogenous response to ischemia? Int J Cardiol 108:410–11.
   PubMed Web of Science ®Google Scholar
• Lippi G, Montagnana M, Salvagno G, Guidi GC. (2006b). Potential value for new diagnostic markers in the early recognition of acute coronary syndromes. CJEM 8:27–31.
   PubMedGoogle Scholar
• Lippi G, Montagnana M, Salvagno G, Guidi GC. (2007). Standarization of ischemia-modified-albumin testing: adjunstement for serum albumin. ClinChem Lab Med 45:261–2.
   Google Scholar
• Ming-Hui Lin R, Fatovich DM, Grasko JM, Vasikaran SD. (2010). Ischaemia modified albumin cannot be used for rapid exclusion of acute coronary syndrome. Emerg Med J [Epub ahead of print].
   Google Scholar
• Morrow DA, de Lemos JA, Sabatine MS, Antman EM. (2003). The search for a biomarker of cardiac ischemia. Clin Chem 49:537–9.
   PubMed Web of Science ®Google Scholar
• Pantazopoulos I, Papadimitriou L, Dontas I, Demestiha T, Lakovidou N, Xanthos T. (2009). Ischaemia modfied albumin in the diagnosis of acute coronary syndromes. Resuscitation 80:306–10.
   Google Scholar
• Peacock F, Morris DL, Anwaruddin S, Christenson RH, Collinson PO, Goodacre SW, Januzzi JL, Jesse RL, Kaski JC, Kontos MC, Lefevre G, Mutrie D, Sinha MK, Uettwiller-Geiger D, Pollack CV. (2006). Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J 152:253–62.
   PubMed Web of Science ®Google Scholar
• Piwowar A, Knapik-Kordecka M, Warwas M. (2008). Ischemia-modified albumin level in type 2 diabetes mellitus – Preliminary report. Dis Markers 24:311–17.
   PubMed Web of Science ®Google Scholar
• Pope JH, Aufderheide TP, Ruthazer R, Woolard RH, Feldman JA, Beshansky JR, Griffith JL, Selker HP. (2000). Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med 342:1163–70.
   PubMed Web of Science ®Google Scholar
• Quiles J, Roy D, Gaze D, Garrido IP, Avanzas P, Sinha M, Kaski JC. (2003) Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia. Am J Cardiol 92:322–4.
   PubMedGoogle Scholar
• Rajappa M, Sharma A. (2005). Biomarkers of cardiac injury: an update. Angiology 56:677–91.
   PubMed Web of Science ®Google Scholar
• Roy D, Quiles J, Aldama G, Sinha M, Avanzas P, Arroyo-Espliguero R, Gaze D, Collinson P, Carlos Kaski J. (2004a). Ischemia modified albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol 97:297–301.
   PubMed Web of Science ®Google Scholar
• Roy D, Quiles J, Sharma R, Sinha M, Avanzas P, Gaze D, Kaski JC. (2004b). Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia. ClinChem 50:1656–60.
   Google Scholar
• Roy D, Quiles J, Sinha M, Aldama G, Gaze D, Kaski JC. (2004c). Effect of direct-current cardioversion on ischemia-modified albumin levels in patients with atrial fibrillation. Am J Cardiol 93:366–8.
   PubMed Web of Science ®Google Scholar
• Roy D, Quiles J, Sinha M, Floros D, Gaze D, Collinson P, Baxter GF, Kaski JC. (2004d). Effect of radiofrequency catheter ablation on the biochemical marker ischemia modified albumin. Am J Cardiol 94:234–6.
   PubMed Web of Science ®Google Scholar
• Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel BJ, Russell RO, Smith EE Jr, Weaver WD. (1996). ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Managementof Acute Myocardial Infarction). J Am CollCardiol 28:1328–428.
   Google Scholar
• Sbarouni E, Georgiadou P, Panagiotakos D, Alivizatos PA, Voudris V. (2009). Increased ischaemia modified albumin following coronary artery bypass grafting. Biomarkers 14:38–42.
   PubMed Web of Science ®Google Scholar
• Sbarouni E, Georgiadou P, Manginas A, Panagiotakos D, Karavolias GK, Voudris V. (2010). Ischaemia-modified albumin in pulmonary hypertension. Biomarkers 15:238–42.
   PubMed Web of Science ®Google Scholar
• Sinha MK, Gaze Dc Tippins, JR, Collinson PO, Kaski JC. (2003). Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 107:2403–5.
   PubMed Web of Science ®Google Scholar
• Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC. (2004). Role of “ischemia modified albumin”, a new biochemical marker of myocardial ischemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 21:29–34.
   PubMed Web of Science ®Google Scholar
• Sinha MK, Vasquez JM, Calvino R, Gaze DC, Collinson PO, Kaski JC. (2006). Effects of balloon occlusion during percutaneous coronary intervention on circulating ischemia modified albumin and transmyocardial lactate extraction. Heart 92:1852–3.
   PubMed Web of Science ®Google Scholar
• Storrow AB, Gibler WB. (2000). Chest pain centers: diagnosis of acute coronary syndromes. Ann Emerg Med 35:449–61.
   PubMed Web of Science ®Google Scholar
• Toutouzas K, Stefanadis C. (2006). Advances in vulnerable plaque detection and treatment: how far have we gone? Hellenic J Cardiol47:129–31.
   Google Scholar
• Turedi S, Gunduz A, Mentese A, Karahan SC, Yilmaz SE, Eroglu O, Nuhoglu I, Turan I, Topbas M. (2007) Value of ischemia-modified albumin in the diagnosis of pulmonary embolism. Am J Emerg Med 25:770–3.
   PubMed Web of Science ®Google Scholar
• Turedi S, Gunduz A, Mentese A, Topbas M, Karahan SC, Yeniocak S, Turan I, Eroglu O, Ucar U, Karaca Y, Turkmen S, Russell RM. (2008). The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism. Respir Res 9:49.
   PubMed Web of Science ®Google Scholar
• Turedi S, Patan T, Gunduz A, Mentese A, Tekinbas C, Topbas M, Karahan SC, Yulug E, Turkmen S, Ucar U. (2009). Ischemia-modified albumin in the diagnosis of pulmonary embolism: an experimental study. Am J Emerg Med 27:635–40.
   PubMed Web of Science ®Google Scholar
• Van Belle E, Dallongeville J, Vicaut E, Degrandsart A, Baulac C, Montalescot G;, OPERA Investigators. (2010). Ischemia-modified albumin levels predict long-term outcome in patients with acute myocardial infarction. The French Nationwide OPERA study. Am Heart J 159:570–6.
   PubMed Web of Science ®Google Scholar
• Worster A, Devereaux PJ, Heels-Ansdell D, Guyatt GH, Opie J, Mookadam F, Hill SA. (2005). Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. CMAJ 172:1685–90.
   PubMed Web of Science ®Google Scholar
• Zapico-Muñiz E, Santaló-Bel M, Mercé-Muntañola J, Montiel JA, Martínez-Rubio A, Ordóñez-Llanos J. (2004). Ischemia-modified albumin during skeletal muscle ischemia. Clin Chem 50:1063–5.
   PubMedGoogle Scholar